MedTrace Logo

Pressure Ulcer Prevention: Turning for Ulcer Reduction

NCT00665535 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 967

Last updated 2012-03-21

No results posted yet for this study

Summary

The purpose of the study is to determine the optimal frequency of repositioning nursing facility residents with limited mobility who are cared for on a high density foam mattress in order to prevent bed sores. It is hypothesized that participants at moderate risk (Braden Scale Scores 13-14) who are turned every 3 or 4 hours and participants at high risk (Braden Scores 10-12) turned every 3 or 4 hours will not have a higher incidence of ulcers than those residents turned every 2 hours.

Conditions

  • Pressure Ulcers

Interventions

PROCEDURE

Turning or repositioning schedule

Turning schedule randomly assigned at 2, 3, or 4 hours

PROCEDURE

Turning or repositioning schedule

Turning schedule randomly assigned at 2, 3 or 4 hours

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • National Institute on Aging (NIA)

    collaborator NIH

  • Ontario Ministry of Health and Long Term Care

    collaborator OTHER_GOV

  • Toronto Health Economic Technology Assessment collaborative (THETA)

    collaborator UNKNOWN

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Nancy Bergstrom, PhD · The University of Texas Health Science Center, Houston

  • Susan Horn, PhD · ISIS, Salt Lake City, UT

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00665535 on ClinicalTrials.gov